Details

Archived 25: Summary of NACI rapid response of December 3, 2021: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T14:14:09.568Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines/summary.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-1/20250418141409/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines/summary.html?wbdisable=true#ha_snapshot=140469
ID: 140469
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots